Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire

• Main Authors: Elisa Camela (Author), Alessia Villani (Author), Sonia Sofia Ocampo Garza (Author), Claudia Costa (Author), Gabriella Fabbrocini (Author), Matteo Megna (Author), Luca Potestio (Author), Angelo Ruggiero (Author), Massimiliano Scalvenzi (Author)
• Format: Book
• Published: Mattioli1885, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

  Introduction: Dysgeusia may occur during conventional or target-therapies and affect patients adherence-to-treatment. Therefore, it should be monitored to improve clinical outcome. To date, available questionnaires on dysgeusia relate to traditional antineoplastics and do not apply to target-thera...